MALFACINI, Davide
 Distribuzione geografica
Continente #
NA - Nord America 4.072
AS - Asia 1.741
EU - Europa 1.303
SA - Sud America 278
AF - Africa 40
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.443
Nazione #
US - Stati Uniti d'America 3.974
SG - Singapore 592
CN - Cina 450
IT - Italia 312
VN - Vietnam 251
DE - Germania 235
BR - Brasile 218
PL - Polonia 170
HK - Hong Kong 132
FI - Finlandia 125
GB - Regno Unito 116
UA - Ucraina 97
TR - Turchia 87
FR - Francia 61
CA - Canada 56
JP - Giappone 52
SE - Svezia 48
RU - Federazione Russa 44
IN - India 34
BD - Bangladesh 31
MX - Messico 30
ID - Indonesia 29
NL - Olanda 28
AR - Argentina 23
BE - Belgio 17
PK - Pakistan 14
IQ - Iraq 12
ZA - Sudafrica 11
EC - Ecuador 9
ES - Italia 9
IE - Irlanda 9
LT - Lituania 9
TN - Tunisia 9
UZ - Uzbekistan 8
VE - Venezuela 8
MA - Marocco 7
CO - Colombia 6
MY - Malesia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
CZ - Repubblica Ceca 5
KR - Corea 4
NP - Nepal 4
PH - Filippine 4
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
BB - Barbados 2
CH - Svizzera 2
CL - Cile 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.443
Città #
Dallas 810
Ashburn 499
Singapore 372
Fairfield 264
Woodbridge 232
San Jose 210
Ann Arbor 192
Warsaw 168
Beijing 157
Houston 150
Chandler 142
Seattle 136
Santa Clara 130
Munich 129
Hong Kong 121
Wilmington 119
Jacksonville 114
Ferrara 97
Cambridge 92
Helsinki 79
Ho Chi Minh City 72
New York 71
Los Angeles 69
Hanoi 50
Tokyo 50
Izmir 43
Nanjing 40
Dong Ket 34
Lauterbourg 31
Milan 31
Princeton 28
Shanghai 27
São Paulo 26
The Dalles 25
Boardman 23
Bologna 21
Council Bluffs 21
Dearborn 20
Jakarta 19
Brussels 17
Chicago 16
Mexico City 16
Brooklyn 15
Fuzhou 15
Toronto 15
Mcallen 14
Montreal 13
Montréal 13
Padova 13
San Diego 13
Amsterdam 12
Frankfurt am Main 12
Moscow 12
Turku 12
Da Nang 11
London 11
Atlanta 10
Haiphong 10
Nanchang 10
Rio de Janeiro 10
Stockholm 10
Boston 9
Buffalo 9
Denver 9
Dublin 9
Hefei 9
Orem 9
Poplar 9
Lahore 8
Tashkent 8
Chennai 7
Columbus 7
Falls Church 7
Phoenix 7
Bremen 6
Changsha 6
Dhaka 6
Jiaxing 6
Johannesburg 6
Nuremberg 6
Rome 6
Auburn Hills 5
Baghdad 5
Brasília 5
Jyväskylä 5
Lappeenranta 5
Manchester 5
Shenyang 5
Tianjin 5
Addison 4
Ankara 4
Augusta 4
Bari 4
Biên Hòa 4
Boydton 4
Brescia 4
Bến Tre 4
Cagliari 4
Calgary 4
City of London 4
Totale 5.427
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 991
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 374
Novel ligands and assays for nociceptin/orphanin FQ and classical opioid receptors 366
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 285
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 262
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 242
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 222
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 219
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 217
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 216
Pharmacological characterization of tachykinin tetrabranched derivatives 212
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 207
null 205
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 203
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 201
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 199
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 196
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 182
Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues 179
NOP receptor pharmacological profile – A dynamic mass redistribution study 178
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 177
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 177
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 171
Pharmacological Assays for Investigating the NOP Receptor 170
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 147
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 135
In vitro and in vivo study of butyrylfentanyl and 4‐fluorobutyrylfentanyl in female and male mice: Role of the CRF1 receptor in cardiorespiratory impairment 130
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study 128
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 128
Pharmacological characterization of naloxegol: In vitro and in vivo studies 112
null 110
null 105
null 103
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 93
null 78
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 64
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 61
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 59
Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity 29
Comprehensive transduceromic profiling of NOP receptor ligands at different Gα subunits 7
Totale 7.540
Categoria #
all - tutte 27.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 939
Totale 28.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 104 66 52
2021/2022265 24 19 2 12 21 21 16 25 17 32 15 61
2022/2023317 32 31 17 42 43 40 17 34 31 3 14 13
2023/2024288 18 23 5 7 14 58 14 57 3 9 17 63
2024/20251.048 29 39 80 32 91 123 80 70 172 89 138 105
2025/20263.407 317 286 819 362 395 217 344 173 240 254 0 0
Totale 7.540